The Medidata Decentralized Clinical Trials Program
Inspired by Patients. Powered by Data. Securely Delivered to Scale.
One Platform For Everyone
The Medidata Decentralized Clinical Trials Program delivers the industry’s only scalable, end-to-end offering for trial decentralization that connects trial experiences for patients, sites, and sponsors.
One Solution For Sites
Medidata’s partnership with Circuit Clinical provides a turnkey solution that enhances patient access and inclusion through site ratings and a national network of decentralized clinical trial sites – all trained and certified on Medidata technology.
One Intuitive User Experience
See how our platform connects users in a single, intuitive user experience.
An End-to-End DCT Solution
Patient Engagement in Clinical Trials
Patient Cloud is a suite of powerful, patient-centric solutions that empowers people with choice so you can virtually recruit the widest, most inclusive pool of participants, keep them engaged throughout your trial, and produce better study results.
Remote Monitoring and Data Quality Oversight
DCTs present opportunities and challenges for clinical data collection and analysis. Medidata solves these challenges with capabilities for centralized, remote, and risk-based monitoring, all on top of a unified data platform. Now you can take a flexible approach to clinical trial monitoring and data quality oversight, shifting from 100% on-site to remote activities, without sacrificing timelines, cost, or data quality.
Ease and Flexibility to Execute Direct-to-Patient (DtP) in Real-time
Rave RTSM has unsurpassed DtP capabilities giving sponsors and CROs the highest level of flexibility for decentralized and hybrid clinical trials. DtP can be enabled for any combination of sites and visits and provides sites the ability to determine the source of the patient’s dispensation.
In addition, only the Medidata platform is truly virtualized allowing patients to confirm incoming shipments using the myMedidata App.
DCT Strategic Design Methodology
Decentralized Clinical Trials (DCTs) are transforming clinical research by delivering better patient experiences and accelerating drug development. But where do you start?
Our Strategic Consulting experts have developed a DCT Strategic Design methodology, which includes design principles, organizational change management, and a ‘whole systems’ approach to create a comprehensive strategy tailored to your organizational needs, now and for the future.
What You Need to Know About DCTs
What Are Decentralized Clinical Trials?
Read the most frequently asked questions on what decentralized clinical trials mean.
Hear From the FDA on Decentralized Clinical Trials
Hear from former Commissioner of the FDA Scott Gottlieb and Medidata co-founder Glen de Vries to understand where the industry is headed with decentralized clinical trials.
Decentralized Clinical Trials: The Future of Clinical Research is Here
Read about the changing landscape around DCTs and the types of solutions used to run decentralized clinical trials.
Clinical Operations and Decentralized Clinical Trials
In this whitepaper, Medidata explains the industry’s move towards risk-based quality management (RBQM) approaches to ensure data oversight for DCTs, and the value such approaches bring to sponsors, CROs, sites, and ultimately patients
Decentralized Clinical Trial Resources
Podcast
The Power of Decentralized Clinical Trials
How do today’s clinical trial technologies affect stakeholders involved in clinical research? Hear from Kelly McKee, VP of Patient Registries & Recruitment at Medidata, as she discusses how decentralized trials improve patient, site, and sponsor experiences on the Pivot Points podcast.
Assessment
Decentralized Clinical Trial Assessment Tool
How comprehensive is your decentralized clinical trial strategy? Find out using our DCT assessment tool.
eBook
Decentralized Clinical Trials: Book of Case Studies
Today’s technologies let patients remotely engage with trial activities, creating better patient experiences and letting sponsors execute faster trials driven by high-quality data. Learn how our end-to-end DCT solutions support the patient, site, and sponsor across the entire trial.
Brief
Remote Monitoring Q&A Brief
Read about Medidata’s holistic, innovative digital solution to enable a flexible on-site/off-site approach to study oversight and improved data quality.
Webinar
Virtual Clinical Trials vs. Clinical Trial Virtualization
Watch the first of the two part webinar series with industry thought leaders from Medidata, Parexel, Circuit Clinical, and Clinical Innovation Partners as they explore the changing paradigm of study conduct to enable virtualization of clinical trials.
Webinar
Yesterday’s Decentralized Clinical Trials Are Today’s Clinical Trials
What was once an emergent trend is now becoming an established practice: decentralized clinical trials, also known as virtual trials. In this second part of the two part series hear industry thought leaders from Medidata, Parexel, Circuit Clinical, and Clinical Innovation Partners discuss the ongoing paradigm changes with DCTs.
One Platform For Everyone
The Medidata Decentralized Clinical Trials Program delivers the industry’s only scalable, end-to-end offering for trial decentralization that connects trial experiences for patients, sites, and sponsors.
One Solution For Sites
Medidata’s partnership with Circuit Clinical provides a turnkey solution that enhances patient access and inclusion through site ratings and a national network of decentralized clinical trial sites – all trained and certified on Medidata technology.
One Intuitive User Experience
See how our platform connects users in a single, intuitive user experience.
An End-to-End DCT Solution
Patient Engagement in Clinical Trials
Patient Cloud is a suite of powerful, patient-centric solutions that empowers people with choice so you can virtually recruit the widest, most inclusive pool of participants, keep them engaged throughout your trial, and produce better study results.
Remote Monitoring and Data Quality Oversight
DCTs present opportunities and challenges for clinical data collection and analysis. Medidata solves these challenges with capabilities for centralized, remote, and risk-based monitoring, all on top of a unified data platform. Now you can take a flexible approach to clinical trial monitoring and data quality oversight, shifting from 100% on-site to remote activities, without sacrificing timelines, cost, or data quality.
Ease and Flexibility to Execute Direct-to-Patient (DtP) in Real-time
Rave RTSM has unsurpassed DtP capabilities giving sponsors and CROs the highest level of flexibility for decentralized and hybrid clinical trials. DtP can be enabled for any combination of sites and visits and provides sites the ability to determine the source of the patient’s dispensation.
In addition, only the Medidata platform is truly virtualized allowing patients to confirm incoming shipments using the myMedidata App.
DCT Strategic Design Methodology
Decentralized Clinical Trials (DCTs) are transforming clinical research by delivering better patient experiences and accelerating drug development. But where do you start?
Our Strategic Consulting experts have developed a DCT Strategic Design methodology, which includes design principles, organizational change management, and a ‘whole systems’ approach to create a comprehensive strategy tailored to your organizational needs, now and for the future.
What You Need to Know About DCTs
What Are Decentralized Clinical Trials?
Read the most frequently asked questions on what decentralized clinical trials mean.
Hear From the FDA on Decentralized Clinical Trials
Hear from former Commissioner of the FDA Scott Gottlieb and Medidata co-founder Glen de Vries to understand where the industry is headed with decentralized clinical trials.
Decentralized Clinical Trials: The Future of Clinical Research is Here
Read about the changing landscape around DCTs and the types of solutions used to run decentralized clinical trials.
Clinical Operations and Decentralized Clinical Trials
In this whitepaper, Medidata explains the industry’s move towards risk-based quality management (RBQM) approaches to ensure data oversight for DCTs, and the value such approaches bring to sponsors, CROs, sites, and ultimately patients
Decentralized Clinical Trial Resources
The Power of Decentralized Clinical Trials
How do today’s clinical trial technologies affect stakeholders involved in clinical research? Hear from Kelly McKee, VP of Patient Registries & Recruitment at Medidata, as she discusses how decentralized trials improve patient, site, and sponsor experiences on the Pivot Points podcast.
Decentralized Clinical Trial Assessment Tool
How comprehensive is your decentralized clinical trial strategy? Find out using our DCT assessment tool.
Decentralized Clinical Trials: Book of Case Studies
Today’s technologies let patients remotely engage with trial activities, creating better patient experiences and letting sponsors execute faster trials driven by high-quality data. Learn how our end-to-end DCT solutions support the patient, site, and sponsor across the entire trial.
Remote Monitoring Q&A Brief
Read about Medidata’s holistic, innovative digital solution to enable a flexible on-site/off-site approach to study oversight and improved data quality.
Virtual Clinical Trials vs. Clinical Trial Virtualization
Watch the first of the two part webinar series with industry thought leaders from Medidata, Parexel, Circuit Clinical, and Clinical Innovation Partners as they explore the changing paradigm of study conduct to enable virtualization of clinical trials.
Yesterday’s Decentralized Clinical Trials Are Today’s Clinical Trials
What was once an emergent trend is now becoming an established practice: decentralized clinical trials, also known as virtual trials. In this second part of the two part series hear industry thought leaders from Medidata, Parexel, Circuit Clinical, and Clinical Innovation Partners discuss the ongoing paradigm changes with DCTs.